Connection
David Hall to Cost-Benefit Analysis
This is a "connection" page, showing publications David Hall has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.225 |
|
|
|
-
Ortendahl JD, Cuyun Carter G, Thakkar SG, Bognar K, Hall DW, Abdou Y, Gandara D. Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non-Small Cell Lung Cancer. JCO Precis Oncol. 2025 Jun; 9:e2400640.
Score: 0.178
-
Ortendahl JD, Carter GC, Zantema EM, Hoag JR, Starodynov A, White KL, Basu GD, Tharayanil A, De La O JP, Hall DW, Baehner FL. Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors. J Med Econ. 2026 Dec; 29(1):1046-1058.
Score: 0.047